Fmoc-Ser(O-α-D-GalNAc(OAc)3)-OH(CAS: 120173-57-1)

Fmoc-Ser(O-α-D-GalNAc(OAc)3)-OH (CAS: 120173-57-1) falls under various regulatory guidelines. Under GHS, it may require classification for health hazards due to its potential for skin irritation. In the EU, it is subject to REACH regulations, requiring supplier notifications and registration if used in quantities above the threshold. FDA and EPA regulations may apply based on intended use, such as in pharmaceuticals or environmental studies.

Alternatives to Fmoc-Ser(O-α-D-GalNAc(OAc)3)-OH (CAS: 120173-57-1) include other Fmoc-protected amino acids or galactosylated serines. Isomers such as the D-isomer or different glycosylation patterns can serve as alternatives. Common alternative reagents include HOBt and Wang resin, which can provide similar functionality in solid-phase peptide synthesis.

The market for Fmoc-Ser(O-α-D-GalNAc(OAc)3)-OH (CAS: 120173-57-1) is growing due to increasing interest in peptide-based therapeutics. Research trends focus on its use in drug discovery for targeting glycosylated peptides, with growing applications in oncology and immunology. Price trends show steady demand, reflecting its importance in specialized research and development.

Waste containing Fmoc-Ser(O-α-D-GalNAc(OAc)3)-OH (CAS: 120173-57-1) should be handled carefully. Collect waste liquids in appropriate containers and ensure proper labeling. For larger quantities, consider incineration or professional waste disposal services. Follow local environmental protection regulations to minimize environmental impact. Always wear protective gear and ensure safe transportation to disposal facilities.